Lili Milani has a Ph.D in molecular medicine, from Uppsala University in Sweden. Her main subjects of research are epigenetics and pharmacogenetics, ranging from studying the variety of drug disintegration within healthy organisms to studying the differences of healthy and sick individuals in the genome and epigenome. She is the Senior Research Fellow of the Tartu University Estonian Biobank and the director of the core laboratory, which enables her to keep up with latest developments in DNA analysis tech. In addition, Lili is involved with developing the strategies for the implementation of personal medicine strategies in Estonia. “We’ve reached a turning point in healthcare, as technology and knowledge progress, new opportunities are created. Genetic research allows us to predict and prevent diseases instead of fighting their consequences.”